Pricing Log in Create free account
Friday 6 November 2026 Export LH’s income statement to Excel — free account

Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.

Revenue
+6.92%
EPS
+3.18%
Free cash flow
+44.7%
Total debt
+3.21%

Quarter to September 2026, against a year earlier

367.05 3.75 +1.03%
Market cap
$29.5B
P/E
29.5×
Fwd P/E
26.7×
Dividend yield
0.79%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Labcorp Holdings Inc. (LH) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Labcorp Holdings Inc. (LH) trades at a EV/EBITDA of 15.6×. Over the past ten years it has ranged from 5.0× (July 2021) to 18.3× (January 2024); the current reading is higher than 91% of that period. That is below the Diagnostics & Research industry median of 23.4× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 12.3× (7.69%)
FY2024 13.4× (26.99%)
FY2023 18.3× 55.04%
FY2022 11.8× 42.79%
FY2021 8.3× 34.77%
FY2020 6.1× (42.40%)
FY2019 10.7× 20.73%
FY2018 8.8× (19.79%)
FY2017 11.0× 20.54%
FY2016 9.1× (15.42%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 13.6× 4.19%
Jun 2026 13.1× 3.42%
Mar 2026 12.6× 2.39%
Dec 2025 12.3× (6.11%)
43 more quarters

Against its own ten years

Low 5.0× High 18.3×
Ten-year median 11.2×
Current reading's percentile 91

EV/EBITDA against peers

Company EV/EBITDA
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.2×
LH Labcorp Holdings Inc. 15.6×
IQV IQVIA Holdings Inc. compare 16.5×
ILMN Illumina, Inc. compare 26.4×
A Agilent Technologies, Inc. compare 26.4×
MEDP Medpace Holdings, Inc. compare 27.0×
MTD Mettler-Toledo International, Inc. compare 27.4×
WAT Waters Corporation compare 51.9×
Diagnostics & Research industry median 23.4×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on LH